What Does "Research Use Only" Mean? RUO Labeling Explained

By the Zen Well Labs Research Team · Last reviewed September 2026 · For laboratory research reference only

Short answer: “Research Use Only” (RUO) means a product is supplied for laboratory research, such as in-vitro experiments, analytical work and assay development, and not for use in humans or animals, clinical diagnosis, or any consumer purpose. An RUO product is not an FDA-approved drug, not a dietary supplement, not a food or cosmetic, and not a compounded medication. The phrase has a formal regulatory definition in one area of US law: FDA’s labeling rule for in-vitro diagnostic (IVD) products, 21 CFR 809.10(c)(2)(i), requires the statement “For Research Use Only. Not for use in diagnostic procedures.” For research chemicals such as peptides, RUO describes the seller’s intended use. Under 21 CFR 201.128, FDA judges that intended use from the full circumstances of sale, not from the label alone. This is why an RUO supplier cannot give administration or human-use guidance: doing so would contradict the research-only intended use.

*This page is general educational information, not legal advice. Regulations change and their application depends on specific facts. Consult qualified regulatory counsel and your institution’s compliance office for guidance on your situation.*

RUO at a glance

Question	Short answer
What does RUO stand for?	Research Use Only
Where is RUO formally defined in US regulation?	For IVD products: 21 CFR 809.10(c)(2)(i)
Main FDA guidance on RUO labeling	Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only (CDRH/CBER, November 2013), which covers IVD products
How is "intended use" judged?	By objective intent shown by labeling, advertising, statements and the circumstances of distribution (21 CFR 201.128)
Is an RUO product FDA-approved?	No
Is an RUO product a dietary supplement?	No
Can an RUO supplier give administration or human-use advice?	No. That would indicate an intended use other than research
Does an RUO label protect a seller who markets for human use?	No. FDA looks at the full marketing context

Where the term "Research Use Only" comes from

The clearest regulatory use of the phrase is in FDA’s device regulations for in-vitro diagnostic products: reagents, instruments and systems used to test specimens taken from the human body. Under 21 CFR 809.10(c), IVD products that are still in development can be shipped without full diagnostic labeling if they meet certain conditions:

RUO: a product “in the laboratory research phase of development, and not represented as an effective in vitro diagnostic product” must carry, prominently placed, the statement “For Research Use Only. Not for use in diagnostic procedures.” (21 CFR 809.10(c)(2)(i)).
IUO (Investigational Use Only): a product in the product-testing phase must carry “For Investigational Use Only. The performance characteristics of this product have not been established.” (21 CFR 809.10(c)(2)(ii)).

In November 2013, FDA’s Center for Devices and Radiological Health and Center for Biologics Evaluation and Research issued final guidance titled *Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only* (Docket FDA-2011-D-0305). FDA said it issued the guidance because unapproved IVD products labeled RUO or IUO were sometimes being distributed for clinical diagnostic use. The guidance reminds manufacturers that RUO and IUO labeling must match the manufacturer’s actual intended use.

An important accuracy point: that regulation and that guidance apply to IVD products. They do not directly govern research peptides, coenzymes or other research chemicals. The broader principle they reflect, that a label must match the real intended use, runs throughout the Federal Food, Drug, and Cosmetic Act (FD&C Act). For research chemicals, the key legal concept is intended use, discussed next.

Intended use: why the label alone is not enough

Under the FD&C Act, whether a product is regulated as a drug, a food, a dietary supplement, a cosmetic or a device depends mostly on its intended use. FDA’s regulation at 21 CFR 201.128 says that intended use “refer[s] to the objective intent of the persons legally responsible for the labeling of an article.” That intent “may be shown by such persons’ expressions, the design or composition of the article, or by the circumstances surrounding the distribution of the article,” including “labeling claims, advertising matter, or oral or written statements.”

The statutory definition of a drug (FD&C Act §201(g)(1), 21 U.S.C. 321(g)(1)) includes articles “intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease” and articles (other than food) “intended to affect the structure or any function of the body.” A product that meets that definition and is not FDA-approved is generally an unapproved new drug under FD&C Act §505(a).

In practice, a research-only intended use has to be consistent across product pages, blog posts, emails, social media and customer service. Two FDA warning letters issued on August 24, 2026 by FDA’s Center for Drug Evaluation and Research show how the agency applies this to online peptide sellers:

NuScience Peptides LLC, MARCS-CMS 733652. The firm’s labeling described its products as “for laboratory, research, and analytical use” and “not intended for human or veterinary use.” FDA wrote that, despite those statements, “evidence obtained from your website establishes that your products are intended to be drugs for human use.”
Royal Peptides LLC, MARCS-CMS 734884. The firm’s labeling said “for research use only” and “not for human or animal consumption.” FDA used the same wording: “evidence obtained from your website establishes that your products are intended to be drugs for human use.”

In both letters, FDA cited “examples from your product labeling, including on your website” as evidence of intended use under 21 CFR 201.128. Several of the quoted passages were written as research descriptions but discussed disease conditions or effects on body functions. In the NuScience letter, FDA also quoted text from a third-party database page that was hyperlinked from a product page. Both letters also pointed to other products and website content suggesting human use. FDA concluded that the products were unapproved new drugs under section 505(a). A research-only label is weighed against everything else a seller publishes and offers.

FDA regulations also recognise research use of prescription-type drugs. 21 CFR 201.125 exempts such drugs from the “adequate directions for use” labeling requirement when they are shipped to, or held by, persons “regularly and lawfully engaged in … research not involving clinical use, or in chemical analysis, or physical testing,” and are used only for those purposes. The limits in that exemption, “not involving clinical use” and “lawfully engaged”, describe the kind of setting RUO material is meant for.

RUO compared with other product categories

Category	Legal basis (US)	Reviewed by FDA before marketing?	Can be sold for human use?	Carries human-use directions?
FDA-approved drug	FD&C Act §505 (NDA/ANDA) or PHS Act §351 (BLA)	Yes, for safety and effectiveness	Yes, as labeled	Yes, FDA-approved labeling
Investigational new drug	21 CFR Part 312 (IND), with IRB oversight (Part 56) and informed consent (Part 50)	IND submitted to FDA before clinical study	Only within an authorised clinical investigation	Protocol-specific
Dietary supplement	FD&C Act §201(ff) (21 U.S.C. 321(ff)), added by DSHEA 1994	No pre-approval (with notification rules for new dietary ingredients)	Yes, for ingestion, within supplement rules	Yes, supplement labeling; disease claims not allowed
Compounded drug	FD&C Act §503A (state-licensed pharmacies, prescription-based) or §503B (registered outsourcing facilities)	Not approved; subject to specific statutory conditions	Only under those conditions	Pharmacy labeling
Research Use Only chemical	No approval pathway; intended use limited to research	No	No	No. Identity, purity and handling information only

Some key distinctions:

RUO vs FDA-approved drugs. An approved drug has gone through FDA review of safety, effectiveness and manufacturing quality, and carries labeling with approved directions for use. An RUO chemical has had none of that review. It is not made or sold under drug manufacturing requirements, and it has no human-use directions.
RUO vs dietary supplements. A dietary supplement is, by statutory definition, a product intended to supplement the diet and intended for ingestion, labeled as a dietary supplement. RUO materials are not intended for ingestion and are not dietary supplements. Calling a research chemical a “supplement”, or vice versa, confuses two different legal categories.
RUO vs compounded products. Compounding under §503A or §503B is a regulated pharmacy activity with its own conditions, such as prescription requirements for 503A and registration and current good manufacturing practice for 503B, plus limits on which bulk drug substances may be used. An RUO supplier is not a pharmacy and does not compound, and RUO material is not a compounding ingredient supplied for that purpose.

Why RUO suppliers cannot give human-use guidance

Customers sometimes ask an RUO supplier how a compound could be used in a person, how to administer it, or what effects to expect. A legitimate RUO supplier cannot answer those questions, for three reasons:

1. It would change the intended use. Under 21 CFR 201.128, a seller’s written or oral statements are evidence of intended use. Human-use guidance is evidence that the product is intended as a drug. 2. There is no approved basis for it. RUO chemicals have no FDA-reviewed safety, effectiveness or labeling data that could support directions for human use. 3. The material is not made for it. Research-grade material is characterised for identity and purity for laboratory work. It is not manufactured, tested or released as a finished drug product.

What an RUO supplier can provide is chemical and analytical reference information: identity (sequence or structure, formula, molecular weight, CAS number), batch Certificates of Analysis, and general laboratory storage and handling information. See, for example, our guides to how to read a peptide COA and lyophilized peptide storage and stability.

Buyer responsibilities: what Zen Well Labs' Terms of Service require

Requirements differ from supplier to supplier. For Zen Well Labs, they are set out in our Terms of Service and our Research Use Disclaimer. This section summarises them. Where it differs from those live pages, they govern.

Buyer representation (Terms of Service). “By placing an order with Zen Well Labs, you explicitly acknowledge, agree, and represent that you are a qualified researcher, institution, or business entity purchasing these compounds strictly for legitimate research applications.”
Age requirement (Terms of Service, section 3). “You must be at least 21 years of age (or the legal age of majority in your jurisdiction) to purchase products from this website. By placing an order, you verify that you meet these age requirements.”
Research-use scope (Research Use Only notice in the zenwelllabs.com site footer). “Products sold by Zen Well Labs are for in vitro research use only — studies performed outside the body, such as in test tubes or petri dishes. These products are not medicines or drugs, have not been approved by the FDA, and are not intended to diagnose, treat, cure or prevent any disease.” The full Research Use Disclaimer uses substantially the same language.
Researcher Verification prompt. When visitors enter the site, a “Researcher Verification” pop-up asks for a single combined confirmation, shown as: “I am 21 years of age or older. I am purchasing for legitimate laboratory research only and agree to the Terms of Service and Research Use Disclaimer.” Visitors choose “Enter Site” to confirm or “I do not agree — leave”.

These are representations and confirmations made by the buyer. Read the full Terms of Service and Research Use Disclaimer before purchasing.

What RUO does not mean

RUO does not mean FDA-approved or FDA-reviewed. FDA does not approve research chemicals.
RUO does not mean safe for people. It means no human-use determination has been made or claimed.
RUO is not a legal loophole. An RUO label does not make human-use marketing lawful. FDA judges intended use from the whole context.
RUO does not mean “pharmaceutical grade”. Terms such as “pharmaceutical grade” or “USP grade” refer to specific compendial and manufacturing standards that RUO material is not represented to meet unless stated and documented.
RUO does not change with the product. The same limits apply whether the material is a peptide such as BPC-157, TB-500, GHK-Cu, ipamorelin, MOTS-c, Epithalon or CJC-1295, or a non-peptide reagent.

Frequently asked questions

What does "Research Use Only" mean on a peptide?

It means the peptide is sold only for laboratory research, such as in-vitro experiments and analytical work. It is not for use in humans or animals, not for diagnosis, and not for any consumer purpose. It is not an FDA-approved drug or a dietary supplement.

Is RUO an official FDA term?

Yes, for in-vitro diagnostic products. 21 CFR 809.10(c)(2)(i) requires the statement “For Research Use Only. Not for use in diagnostic procedures.” for IVD products in the laboratory research phase, and FDA’s 2013 RUO/IUO guidance addresses those IVD products. For research chemicals, RUO describes intended use, which FDA judges from the full circumstances of sale under 21 CFR 201.128.

What is the difference between RUO and IUO?

For IVD products, RUO covers the laboratory research phase of development, and IUO (Investigational Use Only) covers the product-testing phase before full commercial marketing. Each has its own required label statement under 21 CFR 809.10(c).

Why won't an RUO supplier give human-use instructions?

Because administration or human-use guidance would show an intended use other than research, and no FDA-reviewed data exist to support human use. An RUO supplier can provide identity, purity and laboratory handling information only.

Does an RUO label make a product legal to sell for any purpose?

No. FDA looks beyond the label to the seller’s claims, advertising and circumstances of sale. Products marketed for human use can be regarded as unapproved drugs despite an RUO statement.

Is this legal advice?

No. This page is general educational information. For advice on your specific situation, consult qualified regulatory counsel and your institution’s compliance office.

References

21 CFR 809.10, Labeling for in vitro diagnostic products, especially paragraph (c)(2)(i)–(ii). Electronic Code of Federal Regulations.
US Food and Drug Administration (CDRH/CBER). *Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Guidance for Industry and Food and Drug Administration Staff.* November 2013. Docket FDA-2011-D-0305; notice of availability 78 FR 70306 (November 25, 2013).
21 CFR 201.128, Meaning of “intended uses” (as amended 86 FR 41401, August 2, 2021).
21 CFR 201.125, Drugs for use in teaching, law enforcement, research, and analysis.
Federal Food, Drug, and Cosmetic Act §201(g)(1) (21 U.S.C. 321(g)(1)), definition of “drug”; §201(ff) (21 U.S.C. 321(ff)), definition of “dietary supplement”; §505(a) (21 U.S.C. 355(a)); §503A (21 U.S.C. 353a); §503B (21 U.S.C. 353b).
21 CFR Part 312 (Investigational New Drug Application); 21 CFR Part 50 (Protection of Human Subjects); 21 CFR Part 56 (Institutional Review Boards).
US Food and Drug Administration, CDER. Warning Letter to NuScience Peptides LLC, MARCS-CMS 733652, August 24, 2026. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nuscience-peptides-llc-733652-08242026
US Food and Drug Administration, CDER. Warning Letter to Royal Peptides LLC, MARCS-CMS 734884, August 24, 2026. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/royal-peptides-llc-734884-08242026
Zen Well Labs. Terms of Service. https://zenwelllabs.com/terms-of-service/
Zen Well Labs. Research Use Disclaimer (effective September 18, 2026). https://zenwelllabs.com/disclaimer/

Research use only. All products sold by Zen Well Labs are intended strictly for in-vitro laboratory research. They are not drugs, foods, cosmetics or dietary supplements, are not approved by the FDA for any use, and are not for human or veterinary use. Nothing on this page is medical advice, and nothing here describes or recommends administration to humans or animals.

What Does “Research Use Only” Mean?